Clinical Trials Logo

Clinical Trial Summary

The aim of this randomized controlled study is to evaluate the effect of the mobile lymphedema self-care support program on self-care, quality of life and symptoms related to lymphedema in women with breast cancer-related lymphedema. H1: There is a difference between the Lymphedema Self-Care Scale mean score in women who develop lymphedema due to breast cancer, according to the use of the mobile lymphedema self-care support program. H2: There is a difference between the Lymphedema Quality of Life Scale average score in women who develop lymphedema due to breast cancer according to the status of using the mobile lymphedema self-care support program. H4: There is a difference between lymphedema arm circumference measurements according to the use of the mobile lymphedema self-care support program in women who develop lymphedema due to breast cancer. H5: In women who develop lymphedema due to breast cancer, there is a difference in the situation of experiencing symptoms related to lymphedema according to the use of the mobile lymphedema self-care support program.


Clinical Trial Description

The content of the mobile program was developed by the researchers. The mobile lymphedema self-care support program content was reviewed by an expert group consisting of doctors, physiotherapists and nurses working with patients with lymphedema. Patients will be contacted via telephone and will be informed about the study, and the experimental and control groups will be selected through the randomization program among the patients who agree to participate in the study and meet the sampling inclusion criteria. Patients were blinded, and blindness will be achieved in the data analysing stage. All measurements will be made to the experimental and control groups at the same time. The standard lymphedema self-care training will be given to the experimental and the control group. And the experimental group will be educated on how to use the mobile program. When the study is completed, the control group will also be allowed to use the mobile program. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05058495
Study type Interventional
Source Dokuz Eylul University
Contact Zeynep Deveci, MSc
Phone +902582964370
Email [email protected]
Status Recruiting
Phase N/A
Start date September 1, 2021
Completion date December 1, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04824378 - Study on Classification Method of Indocyanine Green Lymphography Based on Deep Learning
Not yet recruiting NCT05022823 - Exercise and Compression for Lymphedema N/A
Recruiting NCT04872738 - Patient Experiences With the COVID-19 Vaccination After Breast Cancer Treatment
Recruiting NCT04446494 - Identification and Preservation of Arm Lymphatics N/A
Not yet recruiting NCT04881604 - Adjustable Compression Wrap Versus Compression Sleeve to Control Breast Cancer-related Lymphedema N/A
Not yet recruiting NCT04934098 - Adjustable Compression Wrap Versus Compression Bandage Reduce to Breast Cancer-related Lymphedema N/A
Enrolling by invitation NCT04165512 - Effectiveness of Stellate Ganglion Block in Breast Cancer Related Lymphedema N/A
Terminated NCT04073823 - A Study Evaluating FT-SW in Unilateral Breast Cancer-Related Lymphedema Patients N/A
Recruiting NCT04690439 - Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema N/A
Recruiting NCT04665882 - Nomogram to Predict Breast Cancer Related Lymphedema N/A
Completed NCT04659564 - Clinical Evaluation of a Novel Wearable Compression Technology in the Treatment of Lymphedema, An Open-Label Controlled Study N/A